US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Innoviva

21.02

-0.0100-0.05%

Volume:55.59K

Turnover:1.17M

Market Cap:1.52B

PE:4.88

High:21.13

Open:21.10

Low:20.93

Close:21.03

52wk High:25.15

52wk Low:16.52

Shares:72.25M

Float Shares:69.02M

Volume Ratio:0.49

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):4.30

EPS(LYR):3.30

ROE:36.68%

ROA:6.95%

PB:1.23

PE(LYR):6.37

Loading ...

Overview Company News Filings

Analysts Have Conflicting Sentiments on These Healthcare Companies: Innoviva (INVA) and Pfizer (PFE)

Basilea Publishes Investor Presentation on Anti-Infectives Strategy and Pipeline Progress

Innoviva management to meet virtually with Cantor Fitzgerald

Armata Swings to FY26 Q2 Net Income of $74.14 Million; Operating Loss Widens to $10.31 Million

Does Innoviva’s Q2 Loss and Buyback-Fueled EPS Shift Change The Bull Case For INVA?

Simply Wall St.

Innoviva, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Innoviva Q2 EPS $(1.14) Misses $0.40 Estimate, Sales $119.600M Beat $110.985M Estimate

Benzinga Earnings

Innoviva Q2 FY26 Swings to Net Loss of $83.4 Million; Revenue Rises 19% to $119.6 Million

Innoviva Q2 Royalty Revenue USD 56.334 Million

Basilea Publishes Investor Presentation on Anti-Infectives Strategy, Pipeline and Hospital Brands Cresemba, Zevtera

Basilea Publishes Investor Presentation on Hospital Anti-infectives Portfolio and Pipeline

Armata Pharmaceuticals Names David House CFO

Armata Pharmaceuticals Announces Press Release Availability

Armata Wins FDA Agreement on Pediatric Study Plan for Ap-sa02 in Complicated S. Aureus Bacteremia

Basilea Publishes Investor Presentation on Anti-infectives Strategy, Pipeline Focus

Is Innoviva (INVA) Undervalued After Nortiva Bio Launch And XACDURO Deal?

Simply Wall St.

Armata Pharma Amends 8-K to Disclose Director Daniel Gilmer Committee Assignment

Armata Pharmaceuticals receives additional USD 2.5 million DoD funding for AP-SA02 program

Innoviva Is Maintained at Buy by BTIG

Innoviva Maintained at Buy as Analyst Highlights Nortiva LYNX Platform Upside, Keeps $46 Price Target Unchanged

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/INVA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INVA\",,,,,undefined,":{"symbol":"INVA","market":"US","secType":"STK","nameCN":"Innoviva","latestPrice":21.02,"timestamp":1787669119119,"preClose":21.03,"halted":0,"volume":55587,"delay":0,"changeRate":-0.00047551117451267533,"floatShares":69021905,"shares":72245485,"eps":4.304385,"marketStatus":"Trading","change":-0.01,"latestTime":"08-25 10:45:19 EDT","open":21.1,"high":21.13,"low":20.93,"amount":1167674.307576,"amplitude":0.00951,"askPrice":21.03,"askSize":58,"bidPrice":21.01,"bidSize":429,"shortable":3,"etf":0,"ttmEps":4.304385,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":21.03,"preHourTrading":{"tag":"盘前","latestPrice":21.3,"preClose":21.03,"latestTime":"09:11 EDT","volume":280,"amount":5915.829919999999,"timestamp":1787663470922,"change":0.27,"changeRate":0.012839,"amplitude":0.095102},"postHourTrading":{"tag":"盘后","latestPrice":21.03,"preClose":21.03,"latestTime":"19:30 EDT","volume":24441,"amount":513971.55,"timestamp":1787614204355,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.485035,"impliedVol":0.3005,"impliedVolPercentile":0.251},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INVA\",,,,,undefined,":{"symbol":"INVA","floatShares":69021905,"roa":"6.95%","roe":"36.68%","lyrEps":3.3,"volumeRatio":0.485035,"shares":72245485,"dividePrice":0,"high":21.13,"amplitude":0.00951,"preClose":21.03,"low":20.93,"week52Low":16.52,"pbRate":"1.23","psRate":"3.45","week52High":25.145,"institutionHeld":0.7409,"latestPrice":21.02,"committee":0.761807,"eps":4.304385,"divideRate":0,"volume":55587,"delay":0,"ttmEps":4.304385,"open":21.1,"prevYearClose":19.99,"prevWeekClose":21.07,"prevMonthClose":20.97,"prevQuarterClose":22.71,"fiveDayClose":21.25,"twentyDayClose":21.81,"sixtyDayClose":21.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"INVA","fiscalQuarterEnding":"2026/06","expectedEps":0.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0.59},{"market":"US","date":"2026-05-06","symbol":"INVA","fiscalQuarterEnding":"2026/03","expectedEps":0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":0.44},{"market":"US","date":"2026-02-25","symbol":"INVA","fiscalQuarterEnding":"2025/12","expectedEps":0.34,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"post","actualEps":1.94},{"market":"US","date":"2025-11-05","symbol":"INVA","fiscalQuarterEnding":"2025/09","expectedEps":0.46,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":1.08},{"market":"US","date":"2025-08-06","symbol":"INVA","fiscalQuarterEnding":"2025/06","expectedEps":0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4,"hold":0,"sell":0.2,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":5,"updateTime":1771560000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INVA","date":"2026-08-21","current":4.885715,"percent":0.373454,"low":-22.913716,"twenty":3.554535,"median":5.462373,"eighty":17.371798,"high":50.287764,"avg":9.000762,"sd":12.479614,"marketCap":1517155185},"quantilePoints":[{"date":"2021-08-27","current":3.84695,"twenty":2.834874,"median":5.264972,"eighty":9.735579,"marketCap":1020180463},{"date":"2021-09-03","current":4.025147,"twenty":2.881226,"median":5.264972,"eighty":9.735579,"marketCap":1067436779},{"date":"2021-09-10","current":4.069696,"twenty":2.891291,"median":5.264972,"eighty":9.735579,"marketCap":1079250858},{"date":"2021-09-17","current":4.101143,"twenty":2.905594,"median":5.264972,"eighty":9.735579,"marketCap":1087590208},{"date":"2021-09-24","current":4.240031,"twenty":2.941086,"median":5.264972,"eighty":9.735579,"marketCap":1124422336},{"date":"2021-10-01","current":4.460156,"twenty":2.973399,"median":5.264972,"eighty":9.735579,"marketCap":1182797785},{"date":"2021-10-08","current":4.420848,"twenty":3.003594,"median":5.264972,"eighty":9.735579,"marketCap":1172373598},{"date":"2021-10-15","current":4.352714,"twenty":3.022236,"median":5.264972,"eighty":9.735579,"marketCap":1154305007},{"date":"2021-10-22","current":4.255754,"twenty":3.039616,"median":5.264972,"eighty":9.735579,"marketCap":1128592011},{"date":"2021-10-29","current":3.919172,"twenty":3.063454,"median":5.264972,"eighty":9.735579,"marketCap":1212638907},{"date":"2021-11-05","current":4.06965,"twenty":3.078287,"median":5.264972,"eighty":9.735579,"marketCap":1259198682},{"date":"2021-11-12","current":3.988796,"twenty":3.144504,"median":5.264972,"eighty":9.735579,"marketCap":1234181489},{"date":"2021-11-19","current":3.829334,"twenty":3.278956,"median":5.264972,"eighty":9.735579,"marketCap":1184842027},{"date":"2021-11-26","current":3.800137,"twenty":3.310817,"median":5.264972,"eighty":9.735579,"marketCap":1175808040},{"date":"2021-12-03","current":3.674364,"twenty":3.366978,"median":5.264972,"eighty":9.735579,"marketCap":1136892408},{"date":"2021-12-10","current":3.690086,"twenty":3.399379,"median":5.264972,"eighty":9.735579,"marketCap":1141756862},{"date":"2021-12-17","current":3.910188,"twenty":3.434335,"median":5.264972,"eighty":9.735579,"marketCap":1209859219},{"date":"2021-12-23","current":3.950615,"twenty":3.463967,"median":5.264972,"eighty":9.735579,"marketCap":1222367815},{"date":"2021-12-31","current":3.874253,"twenty":3.495501,"median":5.264972,"eighty":9.735579,"marketCap":1198740467},{"date":"2022-01-07","current":3.930402,"twenty":3.516963,"median":5.260304,"eighty":9.734772,"marketCap":1216113517},{"date":"2022-01-14","current":3.766448,"twenty":3.526683,"median":5.260304,"eighty":9.734772,"marketCap":1165384210},{"date":"2022-01-21","current":3.631691,"twenty":3.530182,"median":5.260304,"eighty":9.734772,"marketCap":1123688890},{"date":"2022-01-28","current":3.600248,"twenty":3.537296,"median":5.260304,"eighty":9.734772,"marketCap":1113959982},{"date":"2022-02-04","current":3.512656,"twenty":3.548507,"median":5.260304,"eighty":9.734772,"marketCap":1086858023},{"date":"2022-02-11","current":5.031803,"twenty":3.560719,"median":5.260304,"eighty":9.734772,"marketCap":1337724869},{"date":"2022-02-18","current":5.225233,"twenty":3.568459,"median":5.269342,"eighty":9.734772,"marketCap":1389149097},{"date":"2022-02-25","current":5.065784,"twenty":3.574833,"median":5.269342,"eighty":9.734772,"marketCap":1346758855},{"date":"2022-03-04","current":4.513774,"twenty":3.582107,"median":5.269342,"eighty":9.734772,"marketCap":1200004892},{"date":"2022-03-11","current":4.937676,"twenty":3.590711,"median":5.269342,"eighty":9.734772,"marketCap":1312701003},{"date":"2022-03-18","current":4.971693,"twenty":3.59574,"median":5.269342,"eighty":9.734772,"marketCap":1321744519},{"date":"2022-03-25","current":5.126864,"twenty":3.60143,"median":5.269342,"eighty":9.734772,"marketCap":1362997424},{"date":"2022-04-01","current":5.166121,"twenty":3.609038,"median":5.269342,"eighty":9.734772,"marketCap":1373433852},{"date":"2022-04-08","current":5.20276,"twenty":3.621043,"median":5.269342,"eighty":9.734772,"marketCap":1383174518},{"date":"2022-04-14","current":4.980308,"twenty":3.626567,"median":5.269342,"eighty":9.734772,"marketCap":1324034762},{"date":"2022-04-22","current":4.666258,"twenty":3.63727,"median":5.269342,"eighty":9.734772,"marketCap":1240543342},{"date":"2022-04-29","current":6.33037,"twenty":3.649123,"median":5.279209,"eighty":9.734772,"marketCap":1186969681},{"date":"2022-05-06","current":5.731887,"twenty":3.654188,"median":5.29302,"eighty":9.734772,"marketCap":1074751826},{"date":"2022-05-13","current":5.895443,"twenty":3.660684,"median":5.306767,"eighty":9.734772,"marketCap":1105419193},{"date":"2022-05-20","current":6.055282,"twenty":3.684861,"median":5.317914,"eighty":9.734772,"marketCap":1135389574},{"date":"2022-05-27","current":5.746756,"twenty":3.690175,"median":5.332028,"eighty":9.734772,"marketCap":1077539768},{"date":"2022-06-03","current":5.698433,"twenty":3.692734,"median":5.341102,"eighty":9.734772,"marketCap":1068478955},{"date":"2022-06-10","current":5.512574,"twenty":3.702116,"median":5.365506,"eighty":9.734772,"marketCap":1033629674},{"date":"2022-06-17","current":5.493988,"twenty":3.715796,"median":5.371587,"eighty":9.734772,"marketCap":1030144746},{"date":"2022-06-24","current":5.486554,"twenty":3.727935,"median":5.373157,"eighty":9.735579,"marketCap":1028750775},{"date":"2022-07-01","current":5.534877,"twenty":3.748483,"median":5.389184,"eighty":9.735579,"marketCap":1037811588},{"date":"2022-07-08","current":5.382473,"twenty":3.755218,"median":5.393191,"eighty":9.735579,"marketCap":1009235177},{"date":"2022-07-15","current":5.352735,"twenty":3.760182,"median":5.393191,"eighty":9.735579,"marketCap":1003659292},{"date":"2022-07-22","current":5.41221,"twenty":3.770133,"median":5.409218,"eighty":9.735579,"marketCap":1014811062},{"date":"2022-07-29","current":10.046571,"twenty":3.785487,"median":5.413225,"eighty":9.758835,"marketCap":999583566},{"date":"2022-08-05","current":10.116631,"twenty":3.795068,"median":5.425245,"eighty":9.818411,"marketCap":1006554163},{"date":"2022-08-12","current":10.32681,"twenty":3.796195,"median":5.429252,"eighty":9.840354,"marketCap":1027465953},{"date":"2022-08-19","current":9.892439,"twenty":3.796195,"median":5.429252,"eighty":9.840354,"marketCap":984248254},{"date":"2022-08-26","current":9.338967,"twenty":3.796195,"median":5.429252,"eighty":9.775415,"marketCap":929180540},{"date":"2022-09-02","current":9.163818,"twenty":3.796195,"median":5.429252,"eighty":9.732367,"marketCap":911754048},{"date":"2022-09-09","current":9.268907,"twenty":3.796195,"median":5.429252,"eighty":9.707338,"marketCap":922209943},{"date":"2022-09-16","current":8.757471,"twenty":3.796195,"median":5.429252,"eighty":9.630338,"marketCap":871324587},{"date":"2022-09-23","current":8.267053,"twenty":3.796195,"median":5.429252,"eighty":9.579714,"marketCap":822530410},{"date":"2022-09-30","current":8.133939,"twenty":3.796195,"median":5.429252,"eighty":9.553725,"marketCap":809286276},{"date":"2022-10-07","current":8.687411,"twenty":3.796195,"median":5.429252,"eighty":9.509074,"marketCap":864353990},{"date":"2022-10-14","current":9.268907,"twenty":3.796195,"median":5.429252,"eighty":9.481881,"marketCap":922209943},{"date":"2022-10-21","current":9.458069,"twenty":3.796195,"median":5.429252,"eighty":9.462795,"marketCap":941030554},{"date":"2022-10-28","current":9.507111,"twenty":3.796195,"median":5.429252,"eighty":9.454174,"marketCap":945909972},{"date":"2022-11-04","current":9.093758,"twenty":3.796195,"median":5.429252,"eighty":9.416144,"marketCap":904783451},{"date":"2022-11-11","current":3.248503,"twenty":3.791136,"median":5.419645,"eighty":9.398806,"marketCap":950446979},{"date":"2022-11-18","current":3.231807,"twenty":3.779229,"median":5.41221,"eighty":9.375567,"marketCap":945562156},{"date":"2022-11-25","current":3.110167,"twenty":3.76699,"median":5.399413,"eighty":9.361853,"marketCap":909972732},{"date":"2022-12-02","current":3.16741,"twenty":3.7586,"median":5.389907,"eighty":9.33056,"marketCap":926720696},{"date":"2022-12-09","current":3.188875,"twenty":3.755171,"median":5.37765,"eighty":9.296797,"marketCap":933001183},{"date":"2022-12-16","current":3.04577,"twenty":3.73787,"median":5.373157,"eighty":9.268907,"marketCap":891131272},{"date":"2022-12-23","current":3.157869,"twenty":3.721737,"median":5.370871,"eighty":9.219774,"marketCap":923929369},{"date":"2022-12-30","current":3.160254,"twenty":3.712352,"median":5.36017,"eighty":9.204798,"marketCap":924627201},{"date":"2023-01-06","current":3.200801,"twenty":3.701355,"median":5.352735,"eighty":9.167406,"marketCap":936490342},{"date":"2023-01-13","current":3.188875,"twenty":3.692734,"median":5.333088,"eighty":9.128427,"marketCap":933001183},{"date":"2023-01-20","current":3.105397,"twenty":3.690153,"median":5.329081,"eighty":9.105671,"marketCap":908577068},{"date":"2023-01-27","current":3.026689,"twenty":3.683733,"median":5.3133,"eighty":9.078668,"marketCap":885548617},{"date":"2023-02-03","current":3.052925,"twenty":3.660478,"median":5.29997,"eighty":9.014694,"marketCap":893224768},{"date":"2023-02-10","current":2.92413,"twenty":3.653686,"median":5.287269,"eighty":8.978083,"marketCap":855541848},{"date":"2023-02-17","current":2.962291,"twenty":3.648628,"median":5.276993,"eighty":8.933954,"marketCap":866707157},{"date":"2023-02-24","current":2.866887,"twenty":3.638752,"median":5.254827,"eighty":8.904325,"marketCap":838793883},{"date":"2023-03-03","current":3.499917,"twenty":3.631691,"median":5.232918,"eighty":8.868252,"marketCap":748705718},{"date":"2023-03-10","current":3.436224,"twenty":3.621445,"median":5.215864,"eighty":8.835303,"marketCap":735080500},{"date":"2023-03-17","current":3.560425,"twenty":3.618049,"median":5.200863,"eighty":8.793592,"marketCap":761649675},{"date":"2023-03-24","current":3.614564,"twenty":3.609038,"median":5.188804,"eighty":8.750715,"marketCap":773231110},{"date":"2023-03-31","current":3.582717,"twenty":3.603966,"median":5.181688,"eighty":8.730663,"marketCap":766418501},{"date":"2023-04-06","current":3.700549,"twenty":3.603459,"median":5.166475,"eighty":8.69652,"marketCap":791625154},{"date":"2023-04-14","current":3.885258,"twenty":3.602952,"median":5.156788,"eighty":8.674168,"marketCap":831138285},{"date":"2023-04-21","current":3.770611,"twenty":3.602952,"median":5.144341,"eighty":8.639328,"marketCap":806612893},{"date":"2023-04-28","current":3.78335,"twenty":3.602952,"median":5.131002,"eighty":8.607948,"marketCap":809337937},{"date":"2023-05-05","current":3.564265,"twenty":3.59758,"median":5.112713,"eighty":8.591234,"marketCap":762471029},{"date":"2023-05-12","current":3.494309,"twenty":3.592693,"median":5.087608,"eighty":8.556531,"marketCap":814219493},{"date":"2023-05-19","current":3.710771,"twenty":3.591527,"median":5.071127,"eighty":8.536736,"marketCap":864657868},{"date":"2023-05-26","current":3.691093,"twenty":3.591527,"median":5.064054,"eighty":8.482623,"marketCap":860072561},{"date":"2023-06-02","current":3.68547,"twenty":3.591527,"median":5.048603,"eighty":8.459414,"marketCap":858762474},{"date":"2023-06-09","current":3.856953,"twenty":3.591527,"median":5.028738,"eighty":8.411843,"marketCap":898720148},{"date":"2023-06-16","current":3.702337,"twenty":3.591379,"median":5.018866,"eighty":8.377115,"marketCap":862692737},{"date":"2023-06-23","current":3.626435,"twenty":3.591083,"median":5.009226,"eighty":8.316656,"marketCap":845006553},{"date":"2023-06-30","current":3.584267,"twenty":3.588457,"median":4.997281,"eighty":8.273434,"marketCap":835180896},{"date":"2023-07-06","current":3.502743,"twenty":3.585402,"median":4.984566,"eighty":8.205703,"marketCap":816184624},{"date":"2023-07-14","current":3.502743,"twenty":3.582717,"median":4.97316,"eighty":8.092774,"marketCap":816184624},{"date":"2023-07-21","current":3.553344,"twenty":3.578604,"median":4.960924,"eighty":7.943882,"marketCap":827975413},{"date":"2023-07-24","current":3.646114,"twenty":3.578604,"median":4.951555,"eighty":7.851265,"marketCap":849591860},{"date":"2023-08-04","current":3.676782,"twenty":3.578604,"median":4.920901,"eighty":7.690116,"marketCap":857991903},{"date":"2023-08-11","current":3.796738,"twenty":3.578604,"median":4.878742,"eighty":7.636489,"marketCap":885984052},{"date":"2023-08-18","current":3.78558,"twenty":3.578604,"median":4.851698,"eighty":7.588225,"marketCap":883380131},{"date":"2023-08-25","current":3.70189,"twenty":3.578604,"median":4.810688,"eighty":7.51851,"marketCap":863850725},{"date":"2023-09-01","current":3.556827,"twenty":3.576513,"median":4.77312,"eighty":7.491696,"marketCap":829999755},{"date":"2023-09-08","current":3.492664,"twenty":3.575345,"median":4.737931,"eighty":7.464883,"marketCap":815027210},{"date":"2023-09-15","current":3.565196,"twenty":3.568459,"median":4.699861,"eighty":7.442002,"marketCap":831952695},{"date":"2023-09-22","current":3.607041,"twenty":3.565196,"median":4.672499,"eighty":7.427344,"marketCap":841717398},{"date":"2023-09-29","current":3.690731,"twenty":3.565196,"median":4.651074,"eighty":7.40053,"marketCap":861246804},{"date":"2023-10-05","current":3.654465,"twenty":3.565196,"median":4.62178,"eighty":7.325453,"marketCap":852784062},{"date":"2023-10-13","current":3.732576,"twenty":3.565158,"median":4.577072,"eighty":7.277188,"marketCap":871011507},{"date":"2023-10-19","current":3.640517,"twenty":3.565138,"median":4.547791,"eighty":7.210691,"marketCap":849529161},{"date":"2023-10-27","current":3.503823,"twenty":3.564003,"median":4.517808,"eighty":7.142836,"marketCap":817631131},{"date":"2023-11-03","current":17.063397,"twenty":3.561951,"median":4.504077,"eighty":7.079305,"marketCap":851071044},{"date":"2023-11-10","current":17.320376,"twenty":3.561951,"median":4.504077,"eighty":7.079305,"marketCap":863888379},{"date":"2023-11-17","current":17.538808,"twenty":3.561951,"median":4.504077,"eighty":7.079305,"marketCap":874783113},{"date":"2023-11-24","current":17.847182,"twenty":3.561951,"median":4.504077,"eighty":7.079305,"marketCap":890163915},{"date":"2023-12-01","current":17.795787,"twenty":3.561951,"median":4.504077,"eighty":7.079305,"marketCap":887600448},{"date":"2023-12-08","current":18.96504,"twenty":3.562009,"median":4.505701,"eighty":7.088421,"marketCap":945919323},{"date":"2023-12-15","current":19.761675,"twenty":3.562009,"median":4.505701,"eighty":7.088421,"marketCap":985653061},{"date":"2023-12-22","current":20.828137,"twenty":3.562009,"median":4.505701,"eighty":7.088421,"marketCap":1038845001},{"date":"2023-12-27","current":20.905231,"twenty":3.562009,"median":4.505701,"eighty":7.088421,"marketCap":1042690202},{"date":"2024-01-05","current":21.560527,"twenty":3.561836,"median":4.503999,"eighty":7.027752,"marketCap":1075374406},{"date":"2024-01-12","current":21.085116,"twenty":3.561836,"median":4.503999,"eighty":7.027752,"marketCap":1051662336},{"date":"2024-01-19","current":20.622554,"twenty":3.561778,"median":4.49256,"eighty":7.016745,"marketCap":1028591133},{"date":"2024-01-26","current":21.226454,"twenty":3.561836,"median":4.503999,"eighty":7.027752,"marketCap":1058711871},{"date":"2024-02-02","current":20.930929,"twenty":3.561836,"median":4.503999,"eighty":7.027752,"marketCap":1043971935},{"date":"2024-02-09","current":20.044352,"twenty":3.561836,"median":4.513774,"eighty":7.101292,"marketCap":999752130},{"date":"2024-02-16","current":20.558309,"twenty":3.561836,"median":4.547791,"eighty":7.207473,"marketCap":1025386800},{"date":"2024-02-23","current":19.890164,"twenty":3.561836,"median":4.587818,"eighty":7.231069,"marketCap":992061729},{"date":"2024-03-01","current":5.448662,"twenty":3.561894,"median":4.62178,"eighty":7.292204,"marketCap":979244394},{"date":"2024-03-08","current":5.305239,"twenty":3.561894,"median":4.661024,"eighty":7.292204,"marketCap":953468181},{"date":"2024-03-15","current":5.178589,"twenty":3.561894,"median":4.674502,"eighty":7.292204,"marketCap":930706341},{"date":"2024-03-22","current":5.273577,"twenty":3.561894,"median":4.702535,"eighty":7.292204,"marketCap":947777721},{"date":"2024-03-28","current":5.379118,"twenty":3.563872,"median":4.737931,"eighty":7.292204,"marketCap":966745921},{"date":"2024-04-05","current":5.15748,"twenty":3.564451,"median":4.784027,"eighty":7.295421,"marketCap":926912701},{"date":"2024-04-12","current":5.175071,"twenty":3.564451,"median":4.820187,"eighty":7.295421,"marketCap":930074068},{"date":"2024-04-19","current":5.168035,"twenty":3.568459,"median":4.852978,"eighty":7.295421,"marketCap":928809521},{"date":"2024-04-26","current":5.273577,"twenty":3.576068,"median":4.884521,"eighty":7.292204,"marketCap":947777721},{"date":"2024-05-03","current":5.346639,"twenty":3.577349,"median":4.923818,"eighty":7.292204,"marketCap":960908730},{"date":"2024-05-10","current":5.26993,"twenty":3.577349,"median":4.944323,"eighty":7.292204,"marketCap":955907253},{"date":"2024-05-17","current":5.501257,"twenty":3.577349,"median":4.972084,"eighty":7.292204,"marketCap":997867552},{"date":"2024-05-24","current":5.435848,"twenty":3.577349,"median":4.980068,"eighty":7.292204,"marketCap":986003044},{"date":"2024-05-31","current":5.284374,"twenty":3.578976,"median":4.999541,"eighty":7.292204,"marketCap":958527342},{"date":"2024-06-07","current":5.635518,"twenty":3.582717,"median":5.011302,"eighty":7.292204,"marketCap":1022221015},{"date":"2024-06-14","current":5.5047,"twenty":3.586773,"median":5.024798,"eighty":7.295421,"marketCap":998492000},{"date":"2024-06-21","current":5.532241,"twenty":3.589018,"median":5.033735,"eighty":7.298639,"marketCap":1003487582},{"date":"2024-06-28","current":5.576994,"twenty":3.589408,"median":5.048603,"eighty":7.301857,"marketCap":1011605403},{"date":"2024-07-05","current":5.621748,"twenty":3.589408,"median":5.064054,"eighty":7.301857,"marketCap":1019723224},{"date":"2024-07-12","current":5.773222,"twenty":3.591379,"median":5.069575,"eighty":7.301857,"marketCap":1047198927},{"date":"2024-07-15","current":5.759451,"twenty":3.594273,"median":5.071127,"eighty":7.301857,"marketCap":1044701135},{"date":"2024-08-02","current":8.298703,"twenty":3.617753,"median":5.091658,"eighty":7.336178,"marketCap":1206830528},{"date":"2024-08-09","current":7.851287,"twenty":3.625972,"median":5.114717,"eighty":7.405997,"marketCap":1141765533},{"date":"2024-08-16","current":7.92012,"twenty":3.63145,"median":5.130178,"eighty":7.433779,"marketCap":1151775532},{"date":"2024-08-23","current":8.019068,"twenty":3.642748,"median":5.141948,"eighty":7.45523,"marketCap":1166164906},{"date":"2024-08-30","current":8.216963,"twenty":3.653491,"median":5.148915,"eighty":7.487406,"marketCap":1194943654},{"date":"2024-09-06","current":8.350328,"twenty":3.670087,"median":5.157134,"eighty":7.502422,"marketCap":1214338027},{"date":"2024-09-13","current":8.436369,"twenty":3.676298,"median":5.163293,"eighty":7.577349,"marketCap":1226850526},{"date":"2024-09-20","current":8.462181,"twenty":3.690086,"median":5.171553,"eighty":7.606458,"marketCap":1230604276},{"date":"2024-09-27","current":8.14813,"twenty":3.692332,"median":5.181495,"eighty":7.668665,"marketCap":1184933655},{"date":"2024-10-04","current":8.389046,"twenty":3.69637,"median":5.18682,"eighty":7.75512,"marketCap":1219968652},{"date":"2024-10-11","current":8.384744,"twenty":3.702248,"median":5.197757,"eighty":7.813325,"marketCap":1219343027},{"date":"2024-10-18","current":8.677285,"twenty":3.710669,"median":5.204902,"eighty":7.881401,"marketCap":1261885524},{"date":"2024-10-25","current":8.518108,"twenty":3.715796,"median":5.212966,"eighty":7.941415,"marketCap":1238737401},{"date":"2024-10-31","current":8.47939,"twenty":3.724703,"median":5.225371,"eighty":7.980349,"marketCap":1233106776},{"date":"2024-11-08","current":19.38384,"twenty":3.738799,"median":5.234878,"eighty":8.063603,"marketCap":1252021620},{"date":"2024-11-15","current":18.647254,"twenty":3.755218,"median":5.252468,"eighty":8.134453,"marketCap":1204444798},{"date":"2024-11-22","current":18.4728,"twenty":3.757873,"median":5.264972,"eighty":8.162272,"marketCap":1193176603},{"date":"2024-11-29","current":18.404956,"twenty":3.761135,"median":5.273577,"eighty":8.218684,"marketCap":1188794528},{"date":"2024-12-06","current":18.337113,"twenty":3.76629,"median":5.280999,"eighty":8.27455,"marketCap":1184412452},{"date":"2024-12-13","current":17.978512,"twenty":3.772706,"median":5.287503,"eighty":8.30802,"marketCap":1161250052},{"date":"2024-12-20","current":17.377613,"twenty":3.775845,"median":5.297939,"eighty":8.332259,"marketCap":1122437382},{"date":"2024-12-27","current":17.106239,"twenty":3.775845,"median":5.308757,"eighty":8.365871,"marketCap":1104909079},{"date":"2025-01-03","current":16.863941,"twenty":3.778884,"median":5.313054,"eighty":8.386465,"marketCap":1089258809},{"date":"2025-01-10","current":16.776714,"twenty":3.785487,"median":5.325718,"eighty":8.394256,"marketCap":1083624712},{"date":"2025-01-17","current":17.881593,"twenty":3.78558,"median":5.332774,"eighty":8.438975,"marketCap":1154989944},{"date":"2025-01-24","current":17.997896,"twenty":3.78558,"median":5.338757,"eighty":8.461325,"marketCap":1162502074},{"date":"2025-01-31","current":18.317729,"twenty":3.788922,"median":5.349748,"eighty":8.487134,"marketCap":1183160430},{"date":"2025-02-07","current":17.697446,"twenty":3.794072,"median":5.352928,"eighty":8.518108,"marketCap":1143095739},{"date":"2025-02-14","current":17.658678,"twenty":3.794072,"median":5.352928,"eighty":8.518108,"marketCap":1140591695},{"date":"2025-02-21","current":17.5133,"twenty":3.794072,"median":5.352928,"eighty":8.518108,"marketCap":1131201533},{"date":"2025-02-28","current":47.022735,"twenty":3.794072,"median":5.352928,"eighty":8.518108,"marketCap":1099955814},{"date":"2025-03-07","current":47.129909,"twenty":3.793184,"median":5.352735,"eighty":8.515527,"marketCap":1102462836},{"date":"2025-03-14","current":46.594038,"twenty":3.793184,"median":5.352735,"eighty":8.536093,"marketCap":1089927727},{"date":"2025-03-21","current":46.111753,"twenty":3.793184,"median":5.353122,"eighty":8.555967,"marketCap":1078646129},{"date":"2025-03-28","current":47.906923,"twenty":3.793184,"median":5.353122,"eighty":8.573144,"marketCap":1120638744},{"date":"2025-04-04","current":48.442795,"twenty":3.793184,"median":5.353122,"eighty":8.676508,"marketCap":1133173853},{"date":"2025-04-11","current":45.817024,"twenty":3.794072,"median":5.353676,"eighty":8.711262,"marketCap":1071751819},{"date":"2025-04-17","current":48.469588,"twenty":3.794072,"median":5.353676,"eighty":8.786896,"marketCap":1133800609},{"date":"2025-04-25","current":49.321723,"twenty":3.793184,"median":5.353122,"eighty":9.089554,"marketCap":1153733755},{"date":"2025-05-02","current":50.046254,"twenty":3.793184,"median":5.353122,"eighty":9.161016,"marketCap":1170681966},{"date":"2025-05-09","current":-19.529213,"twenty":3.785799,"median":5.350974,"eighty":9.242284,"marketCap":1166362714},{"date":"2025-05-16","current":-19.266441,"twenty":3.780033,"median":5.341102,"eighty":9.242284,"marketCap":1150668921},{"date":"2025-05-23","current":-19.781474,"twenty":3.767718,"median":5.333088,"eighty":9.242284,"marketCap":1181428755},{"date":"2025-05-30","current":-20.485703,"twenty":3.762308,"median":5.329081,"eighty":9.242284,"marketCap":1223488121},{"date":"2025-06-06","current":-22.251531,"twenty":3.756175,"median":5.3133,"eighty":9.242284,"marketCap":1328950412},{"date":"2025-06-13","current":-22.493281,"twenty":3.746652,"median":5.308757,"eighty":9.242284,"marketCap":1343388702},{"date":"2025-06-20","current":-22.556346,"twenty":3.728267,"median":5.297483,"eighty":9.247889,"marketCap":1347155212},{"date":"2025-06-27","current":-21.431682,"twenty":3.715923,"median":5.287386,"eighty":9.247889,"marketCap":1279985777},{"date":"2025-07-03","current":-20.191398,"twenty":3.710771,"median":5.282687,"eighty":9.247889,"marketCap":1205911073},{"date":"2025-07-11","current":-20.033735,"twenty":3.702337,"median":5.273644,"eighty":9.247889,"marketCap":1196494797},{"date":"2025-07-18","current":-20.895627,"twenty":3.69631,"median":5.262238,"eighty":9.247889,"marketCap":1247970439},{"date":"2025-07-25","current":-19.886583,"twenty":3.691093,"median":5.251388,"eighty":9.247889,"marketCap":1187706273},{"date":"2025-08-01","current":-19.098267,"twenty":3.68547,"median":5.233898,"eighty":9.247889,"marketCap":1140624893},{"date":"2025-08-08","current":30.100854,"twenty":3.676782,"median":5.228182,"eighty":9.268907,"marketCap":1163367918},{"date":"2025-08-15","current":34.046903,"twenty":3.676782,"median":5.228182,"eighty":9.402021,"marketCap":1315878772},{"date":"2025-08-22","current":32.563059,"twenty":3.676782,"median":5.228182,"eighty":9.472081,"marketCap":1258529649},{"date":"2025-08-29","current":32.660894,"twenty":3.676782,"median":5.233898,"eighty":9.500105,"marketCap":1262310910},{"date":"2025-09-05","current":34.112127,"twenty":3.676298,"median":5.250308,"eighty":9.578571,"marketCap":1318399612},{"date":"2025-09-12","current":31.682535,"twenty":3.676782,"median":5.255916,"eighty":9.871421,"marketCap":1224498302},{"date":"2025-09-19","current":32.432611,"twenty":3.676782,"median":5.271818,"eighty":10.018547,"marketCap":1253487968},{"date":"2025-09-26","current":30.28022,"twenty":3.676782,"median":5.279175,"eighty":10.137649,"marketCap":1170300229},{"date":"2025-10-03","current":28.788222,"twenty":3.676782,"median":5.287269,"eighty":10.32681,"marketCap":1112636002},{"date":"2025-10-10","current":28.453949,"twenty":3.676782,"median":5.295111,"eighty":16.776714,"marketCap":1099716694},{"date":"2025-10-17","current":28.12783,"twenty":3.676782,"median":5.306998,"eighty":16.980244,"marketCap":1087112491},{"date":"2025-10-24","current":29.774735,"twenty":3.676782,"median":5.315568,"eighty":17.135315,"marketCap":1150763715},{"date":"2025-10-31","current":29.269249,"twenty":3.676782,"median":5.33034,"eighty":17.307527,"marketCap":1131227201},{"date":"2025-11-07","current":12.083391,"twenty":3.676782,"median":5.336998,"eighty":17.367921,"marketCap":1538747295},{"date":"2025-11-14","current":13.034561,"twenty":3.676782,"median":5.348175,"eighty":17.367921,"marketCap":1659873176},{"date":"2025-11-21","current":12.423933,"twenty":3.676782,"median":5.353676,"eighty":17.367921,"marketCap":1582113351},{"date":"2025-11-28","current":12.758604,"twenty":3.676782,"median":5.361528,"eighty":17.367921,"marketCap":1624731717},{"date":"2025-12-05","current":12.212562,"twenty":3.676782,"median":5.368564,"eighty":17.367921,"marketCap":1555196489},{"date":"2025-12-12","current":12.106876,"twenty":3.676782,"median":5.372717,"eighty":17.367921,"marketCap":1541738058},{"date":"2025-12-19","current":11.783948,"twenty":3.676782,"median":5.373131,"eighty":17.367921,"marketCap":1500615074},{"date":"2025-12-26","current":11.607805,"twenty":3.676782,"median":5.373131,"eighty":17.367921,"marketCap":1478184355},{"date":"2026-01-02","current":11.736977,"twenty":3.676782,"median":5.373131,"eighty":17.367921,"marketCap":1494633549},{"date":"2026-01-09","current":11.537348,"twenty":3.676782,"median":5.373131,"eighty":17.367921,"marketCap":1469212068},{"date":"2026-01-16","current":11.601934,"twenty":3.676782,"median":5.373131,"eighty":17.367921,"marketCap":1477436665},{"date":"2026-01-23","current":11.590191,"twenty":3.676782,"median":5.373131,"eighty":17.367921,"marketCap":1475941283},{"date":"2026-01-30","current":11.596062,"twenty":3.676782,"median":5.373131,"eighty":17.367921,"marketCap":1476688974},{"date":"2026-02-06","current":12.664662,"twenty":3.676782,"median":5.373131,"eighty":17.367921,"marketCap":1612768667},{"date":"2026-02-13","current":13.175475,"twenty":3.676782,"median":5.373131,"eighty":17.367921,"marketCap":1677817751},{"date":"2026-02-20","current":13.880046,"twenty":3.676782,"median":5.373157,"eighty":17.367921,"marketCap":1767540625},{"date":"2026-02-27","current":6.490748,"twenty":3.676782,"median":5.377407,"eighty":17.367921,"marketCap":1760063719},{"date":"2026-03-06","current":6.05887,"twenty":3.676782,"median":5.387687,"eighty":17.367921,"marketCap":1642953468},{"date":"2026-03-13","current":6.001505,"twenty":3.676782,"median":5.393191,"eighty":17.367921,"marketCap":1627398002},{"date":"2026-03-20","current":6.034285,"twenty":3.676782,"median":5.393408,"eighty":17.367921,"marketCap":1636286840},{"date":"2026-03-27","current":6.188128,"twenty":3.676782,"median":5.404854,"eighty":17.367921,"marketCap":1678003862},{"date":"2026-04-02","current":6.392943,"twenty":3.676782,"median":5.41221,"eighty":17.367921,"marketCap":1733542384},{"date":"2026-04-10","current":6.608681,"twenty":3.676782,"median":5.412717,"eighty":17.367921,"marketCap":1792042960},{"date":"2026-04-17","current":6.444829,"twenty":3.676782,"median":5.430565,"eighty":17.367921,"marketCap":1747612143},{"date":"2026-04-24","current":6.412059,"twenty":3.676782,"median":5.436557,"eighty":17.367921,"marketCap":1738725979},{"date":"2026-05-01","current":6.278247,"twenty":3.676782,"median":5.459188,"eighty":17.367921,"marketCap":1702440812},{"date":"2026-05-08","current":3.347658,"twenty":3.673993,"median":5.472701,"eighty":17.367921,"marketCap":1688371053},{"date":"2026-05-15","current":3.345471,"twenty":3.662834,"median":5.472701,"eighty":17.367921,"marketCap":1687268002},{"date":"2026-05-22","current":3.248882,"twenty":3.646114,"median":5.472701,"eighty":17.367921,"marketCap":1638554227},{"date":"2026-05-29","current":3.203515,"twenty":3.638371,"median":5.471685,"eighty":17.369859,"marketCap":1615673515},{"date":"2026-06-05","current":3.243028,"twenty":3.629246,"median":5.471685,"eighty":17.367921,"marketCap":1635601877},{"date":"2026-06-12","current":3.284005,"twenty":3.623624,"median":5.471685,"eighty":17.367921,"marketCap":1656268327},{"date":"2026-06-18","current":3.313274,"twenty":3.614564,"median":5.471685,"eighty":17.367921,"marketCap":1671030077},{"date":"2026-06-26","current":3.41718,"twenty":3.600248,"median":5.471685,"eighty":17.369859,"marketCap":1723434289},{"date":"2026-07-02","current":3.204978,"twenty":3.591436,"median":5.471685,"eighty":17.369859,"marketCap":1616411603},{"date":"2026-07-10","current":3.248882,"twenty":3.582717,"median":5.453061,"eighty":17.369859,"marketCap":1638554227},{"date":"2026-07-17","current":3.250346,"twenty":3.576481,"median":5.453061,"eighty":17.369859,"marketCap":1639292315},{"date":"2026-07-24","current":3.102536,"twenty":3.56361,"median":5.453061,"eighty":17.369859,"marketCap":1564745478},{"date":"2026-07-31","current":3.105463,"twenty":3.560101,"median":5.462373,"eighty":17.371798,"marketCap":1566221653},{"date":"2026-08-07","current":4.269173,"twenty":3.554535,"median":5.462373,"eighty":17.371798,"marketCap":1525102188},{"date":"2026-08-14","current":4.196368,"twenty":3.554535,"median":5.462373,"eighty":17.371798,"marketCap":1499093813},{"date":"2026-08-21","current":4.246927,"twenty":3.554535,"median":5.462373,"eighty":17.371798,"marketCap":1517155185}],"updateTime":1787642406543},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INVA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661298436","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Innoviva (INVA) and Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661298436","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661298436?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:30","pubTimestamp":1787315415,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Innoviva (INVA) and Pfizer (PFE). Innoviva (INVA) Cantor Fitzgera...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-innoviva-inva-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-innoviva-inva-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2596442595.SGD","LU0321505439.SGD","BK4533","IE00B19Z3B42.SGD","LU0306807586.USD","SG9999001176.USD","SG9999002224.SGD","SG9999013999.USD","BK4550","LU0058720904.USD","LU0122379950.USD","LU0225771236.USD","LU0985481810.HKD","LU1023059063.AUD","BK4007","LU1066053197.SGD","SG9999001176.SGD","IE00BBT3K403.USD","IE00BLSP4239.USD","OZEM","LU1066051498.USD","LU0170899867.USD","SGXZ57979304.SGD","BK4599","LU1894683348.USD","INVA","SG9999002232.USD","BK4592","BK4581","LU1883839398.USD","IE00BLSP4452.SGD","LU0289739699.SGD","LU0321505868.SGD","LU0456855351.SGD","BK4568","IE0002270589.USD","LU1057294990.SGD","IE000M9KFDE8.USD","LU0868494617.USD","LU1894683264.USD","IE00B3T34201.USD","IE00B19Z3581.USD","BK4585","LU0306806265.USD","LU0234572021.USD","BK4534","PFE","SG9999003800.SGD","LU0225284248.USD","BK4588","SG9999011175.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660545904","title":"Basilea Publishes Investor Presentation on Anti-Infectives Strategy and Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2660545904","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660545904?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:27","pubTimestamp":1787030826,"startTime":"0","endTime":"0","summary":"Basilea publishes investor presentation on anti-infectives strategy and pipeline progressBasilea outlined an anti-infectives strategy built on partnerships, milestone and royalty income, low commercia","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL79qVdg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","FHLC","IE00B19Z3581.USD","LU1934455277.USD","RXL","LU1023059063.AUD","AGNG","LU0198837287.USD","LU0158827948.USD","IYH","LU0057025933.USD","PPH","LU2129689431.USD","LU0203345920.USD","FTXH","GLAM","IXJ","LU0661504455.SGD","LU0029864427.USD","LU0868494708.USD","LU1496350502.SGD","BK4588","LU0823416689.USD","LU2125909593.SGD","PJP","JDOC","IE00BSNM7G36.USD","LU0949170772.SGD","SG9999001440.SGD","VHT","ABBV","LU0965509101.SGD","XLV","IE00BGHQF631.EUR","LU2133065610.SGD","LU2237443549.SGD","LU0211327993.USD","LU2125909247.SGD","TRUH","LU0069063385.USD","LU0943347566.SGD","LU1003077747.HKD","MEDX","LU0965509010.AUD","INVA","LU1551013425.SGD","LU0511384066.AUD","LU1093756168.USD","LU1496350171.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660858864","title":"Innoviva management to meet virtually with Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2660858864","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660858864?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:41","pubTimestamp":1786956077,"startTime":"0","endTime":"0","summary":"Virtual Meeting to be held on August 19 hosted by Cantor Fitzgerald. Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/innoviva-management-to-meet-virtually-with-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/innoviva-management-to-meet-virtually-with-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907231","title":"Armata Swings to FY26 Q2 Net Income of $74.14 Million; Operating Loss Widens to $10.31 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907231","media":"Reuters","labels":["executive","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907231?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:06","pubTimestamp":1786565193,"startTime":"0","endTime":"0","summary":"Armata swings to FY26 Q2 net income of $74.14 million; operating loss widens to $10.31 millionArmata Pharmaceuticals posted Q2 net income of USD 74.14 million, swinging from a net loss a year earlier.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL8rLMzC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4139","BK4007","INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658817673","title":"Does Innoviva’s Q2 Loss and Buyback-Fueled EPS Shift Change The Bull Case For INVA?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658817673","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658817673?lang=en_us&edition=fundamental","pubTime":"2026-08-08 23:21","pubTimestamp":1786202477,"startTime":"0","endTime":"0","summary":"In August 2026, Innoviva, Inc. reported second-quarter revenue of US$119.59 million, up from US$100.28 million a year earlier, but swung from net income of US$63.69 million to a net loss of US$83.42 million, alongside a loss per share of US$1.14 from continuing operations. \nDespite this quarterly loss, Innoviva’s six-month results showed revenue rising to US$217.59 million and net income increasing to US$103.18 million, while the company also completed a US$66.40 million buyback program that...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inva/innoviva/news/does-innovivas-q2-loss-and-buyback-fueled-eps-shift-change-t","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inva/innoviva/news/does-innovivas-q2-loss-and-buyback-fueled-eps-shift-change-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657522571","title":"Innoviva, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657522571","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657522571?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:51","pubTimestamp":1785966688,"startTime":"0","endTime":"0","summary":"Innoviva, Inc. reports results for the quarter ended June 30 - Earnings SummaryInnoviva, Inc.INVA.OQreported a quarterly adjusted loss of $1.14 per share for the quarter ended June 30, lower than the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4423NL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657575683","title":"Innoviva Q2 EPS $(1.14) Misses $0.40 Estimate, Sales $119.600M Beat $110.985M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657575683","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657575683?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:43","pubTimestamp":1785962614,"startTime":"0","endTime":"0","summary":"Innoviva (NASDAQ:INVA) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $0.40 by 385 percent. This is a 248.05 percent decrease over earnings of $0.77 per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60974723/innoviva-q2-eps-1-14-misses-0-40-estimate-sales-119-600m-beat-110-985m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Innoviva Q2 EPS $(1.14) Misses $0.40 Estimate, Sales $119.600M Beat $110.985M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657578081","title":"Innoviva Q2 FY26 Swings to Net Loss of $83.4 Million; Revenue Rises 19% to $119.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657578081","media":"Reuters","labels":["shareholding","corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657578081?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:27","pubTimestamp":1785961679,"startTime":"0","endTime":"0","summary":"Innoviva Q2 FY26 swings to net loss of $83.4 million; revenue rises 19% to $119.6 millionInnoviva posted Q2 total revenue of $119.6 million, up 19% year-over-year; operating income rose to $50.9 milli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL4ZTyZ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657527009","title":"Innoviva Q2 Royalty Revenue USD 56.334 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657527009","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657527009?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:06","pubTimestamp":1785960361,"startTime":"0","endTime":"0","summary":"BRIEF-Innoviva Q2 Royalty Revenue USD 56.334 MillionAug 05 (Reuters) - Innoviva Q2 pretax profit USD -108.02 million.Q2 net income USD -83.42 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXXGJF3V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657590789","title":"Basilea Publishes Investor Presentation on Anti-Infectives Strategy, Pipeline and Hospital Brands Cresemba, Zevtera","url":"https://stock-news.laohu8.com/highlight/detail?id=2657590789","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657590789?lang=en_us&edition=fundamental","pubTime":"2026-08-05 13:45","pubTimestamp":1785908721,"startTime":"0","endTime":"0","summary":"Basilea publishes investor presentation on anti-infectives strategy, pipeline and hospital brands Cresemba, ZevteraBasilea highlighted a partnership-led, asset-light anti-infectives model built around","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDLbZYC1p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","IE00BLSP4452.SGD","TRUH","LU0965509101.SGD","SG9999001440.SGD","BK4534","LU0432979614.USD","JDOC","ABBV","LU1585245621.USD","LU1923622614.USD","LU2433249047.HKD","LU0158827948.USD","LU1929549753.HKD","IE000WAW04H5.SGD","LU2133065610.SGD","LU1934455277.USD","IE00BBT3K403.USD","VHT","LU1496350502.SGD","LU0965509283.SGD","LU0795875169.SGD","PJP","LU0203347892.USD","IXJ","LU0795875086.SGD","FHLC","LU0985320562.USD","IE00BFTCPJ56.SGD","SG9999003800.SGD","GLAM","FTXH","AGNG","SG9999015978.USD","XLV","LU0128525929.USD","PPH","INVA","LU0124676726.USD","LU0289739699.SGD","LU0868494708.USD","RXL","LU0859254822.USD","BK4585","IYH","MEDX","LU2129689605.HKD","LU0234572021.USD","LU1718418525.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655856430","title":"Basilea Publishes Investor Presentation on Hospital Anti-infectives Portfolio and Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2655856430","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655856430?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:44","pubTimestamp":1785303847,"startTime":"0","endTime":"0","summary":"Basilea publishes investor presentation on hospital anti-infectives portfolio and pipelineBasilea highlighted two marketed hospital anti-infectives, Cresemba and Zevtera, as its current revenue base.C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL9jr87G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","VHT","FHLC","LU1074936037.SGD","GLAM","LU1718418525.SGD","IE00B19Z3B42.SGD","LU0256863902.USD","XLV","LU0170899867.USD","BK4559","LU1430594728.SGD","SG9999001440.SGD","LU2089283258.USD","LU0545039389.USD","LU0211328371.USD","INVA","LU2133065610.SGD","AGNG","LU0943347566.SGD","LU0203347892.USD","TRUH","IE000F7OJYX1.SGD","IE00BVYPNV92.GBP","BK4139","RXL","SG9999015986.USD","IXJ","IE00BBT3K403.USD","IE00B3PB1722.GBP","LU0203345920.USD","LU2089984988.USD","IYH","LU1934455863.HKD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","PJP","LU0965508806.USD","LU0417517546.SGD","LU0708994859.HKD","LU2468319806.SGD","BK4534","LU0310800379.SGD","LU2237443895.HKD","MEDX","JDOC","LU0158827948.USD","LU1929549753.HKD","PPH","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652053297","title":"Armata Pharmaceuticals Names David House CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2652053297","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652053297?lang=en_us&edition=fundamental","pubTime":"2026-07-20 19:03","pubTimestamp":1784545407,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals names David House CFOArmata Pharmaceuticals promoted David House to chief financial officer as it prepares to advance AP-SA02 into Phase 3.House previously served as senior vice","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDLbZFH7K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA","BK4007","ARMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115268","title":"Armata Pharmaceuticals Announces Press Release Availability","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115268","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115268?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:05","pubTimestamp":1783940723,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals announces press release availabilityArmata Pharmaceuticals disclosed FDA agreement on an initial pediatric study plan for AP-SA02 in complicated Staphylococcus aureus bacteremia","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL5sT7lY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4139","INVA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115495","title":"Armata Wins FDA Agreement on Pediatric Study Plan for Ap-sa02 in Complicated S. Aureus Bacteremia","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115495","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115495?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:00","pubTimestamp":1783940451,"startTime":"0","endTime":"0","summary":"Armata wins FDA agreement on pediatric study plan for AP-SA02 in complicated S. aureus bacteremiaArmata Pharmaceuticals secured FDA agreement on an initial pediatric study plan for AP-SA02 in complica","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL7GfQtz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA","BK4139","BK4007","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647558105","title":"Basilea Publishes Investor Presentation on Anti-infectives Strategy, Pipeline Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2647558105","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647558105?lang=en_us&edition=fundamental","pubTime":"2026-06-30 12:11","pubTimestamp":1782792704,"startTime":"0","endTime":"0","summary":"Basilea publishes investor presentation on anti-infectives strategy, pipeline focusBasilea outlined an asset-light, partnership-led anti-infectives model built around royalties, milestones, limited se","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL3gm43L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","IE000F7OJYX1.SGD","IE0004445239.USD","LU1023059063.AUD","IE00BBT3K403.USD","LU1093756168.USD","BK4007","IE00BJJMRZ35.SGD","LU1551013425.SGD","IE00BLSP4239.USD","LU2468319806.SGD","LU0511384066.AUD","LU0942090050.USD","LU0158827948.USD","LU2129689605.HKD","IE0002270589.USD","IE00BLSP4452.SGD","IE00BVYPNW00.USD","LU2087621335.USD","LU1732799900.SGD","IE000SO60NU8.SGD","LU2347655156.SGD","INVA","LU0029864427.USD","IE0009355771.USD","BK4588","BK4585","LU0882574055.USD","LU0965509010.AUD","BK4559","LU2237443978.SGD","LU2089984988.USD","LU1057294990.SGD","LU1839511570.USD","LU0289739699.SGD","LU0708994859.HKD","LU0661504455.SGD","LU0058720904.USD","LU2112291526.USD","ABBV","LU0203345920.USD","LU0795875169.SGD","IE00B42XCP33.USD","LU0114720955.EUR","LU2089284900.SGD","LU2129689514.USD","LU0795875086.SGD","IE000MB6IJN5.SGD","LU1934455194.USD","LU0211327993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647101353","title":"Is Innoviva (INVA) Undervalued After Nortiva Bio Launch And XACDURO Deal?","url":"https://stock-news.laohu8.com/highlight/detail?id=2647101353","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647101353?lang=en_us&edition=fundamental","pubTime":"2026-06-28 22:13","pubTimestamp":1782655987,"startTime":"0","endTime":"0","summary":"Innoviva event recap and why it matters for shareholders\nInnoviva (INVA) has attracted fresh attention after launching Nortiva Bio, a clinical-stage subsidiary built around the LYNX long-acting oral drug platform, alongside a new XACDURO distribution and licensing agreement with Dr. Reddy's Laboratories.\nSee our latest analysis for Innoviva.\nAgainst this backdrop, Innoviva’s share price return of 18.62% year to date and 10.04% 1 month share price return point to building momentum, while the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inva/innoviva/news/is-innoviva-inva-undervalued-after-nortiva-bio-launch-and-xa","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inva/innoviva/news/is-innoviva-inva-undervalued-after-nortiva-bio-launch-and-xa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","INVA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646184543","title":"Armata Pharma Amends 8-K to Disclose Director Daniel Gilmer Committee Assignment","url":"https://stock-news.laohu8.com/highlight/detail?id=2646184543","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646184543?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:20","pubTimestamp":1782332400,"startTime":"0","endTime":"0","summary":"Armata Pharma amends 8-K to disclose director Daniel Gilmer committee assignmentArmata Pharmaceuticals filed an amended Form 8-K to update missing details from its April 24 director appointment disclo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL87QQ56:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INVA","BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645838414","title":"Armata Pharmaceuticals receives additional USD 2.5 million DoD funding for AP-SA02 program","url":"https://stock-news.laohu8.com/highlight/detail?id=2645838414","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645838414?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:01","pubTimestamp":1782212490,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals received USD 2.5 million in additional non-dilutive U.S. Department of Defense funding for AP-SA02.Total DoD support for the program reached USD 28.7 million; funds target Phase 3 readiness in complicated Staphylococcus aureus bacteremia.Award flows through the Medical Technology Enterprise Consortium; program managed by the Naval Medical Research Command.Armata targets a Phase 3 superiority study start in 2H 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL9ZPkSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARMP","BK4139","INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645008933","title":"Innoviva Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2645008933","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645008933?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:20","pubTimestamp":1782163200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 22, 2026 17:20 ET (21:20 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029154","title":"Innoviva Maintained at Buy as Analyst Highlights Nortiva LYNX Platform Upside, Keeps $46 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029154","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029154?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:46","pubTimestamp":1782125177,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Innoviva, with a price target of $46.00. Ram Selvaraju ha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/innoviva-maintained-at-buy-as-analyst-highlights-nortiva-lynx-platform-upside-keeps-46-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/innoviva-maintained-at-buy-as-analyst-highlights-nortiva-lynx-platform-upside-keeps-46-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INVA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":64,"code":"91000000","status":"200"}]}}